MedTrace Logo

Assessment of Subarachnoid Anesthesia With Low Dose of Pethidine and Combination of Ropivacaine With Fentanyl for Urologic Surgical Operations.

NCT03260283 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2020-03-31

No results posted yet for this study

Summary

The aim of this study is to assess the efficacy of subarachnoid anesthesia with low dose of pethidine (0.4mgkg-1) compared to administration of ropivacaine and fentanyl which is nowadays the common practice.

Conditions

  • Low Dose of Pethidine for Subarachnoid Anesthesia

Interventions

DRUG

Pethidine hydrochloride

In Group I patients will be administered with low dose of pethidine hydrochloride (0.4 mgkg-1) diluted into normal saline up to 2 ml of total volume in order to perform subarachnoid anesthesia for urologic operations

DRUG

Ropivacaine HCl Inj 7.5 MG/ML

In Group II patients will be administered with 2 ml of ropivacaine (0.75%)

DRUG

Fentanyl

15 mcg of fentanyl will be added to the solution in order to perform subarachnoid anesthesia for urologic operations

Sponsors & Collaborators

  • Saint Savvas Anticancer Hospital

    lead OTHER

Principal Investigators

  • Sofia Poulopoulou, Head of department · Anticancer Hospital of Athens 'Saint Savvas'

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-16
Primary Completion
2018-11-29
Completion
2019-12-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03260283 on ClinicalTrials.gov